Blood lipoprotein remodelling after non-severe paediatric burns: A longitudinal analysis beyond the acute phase
16 affiliations
- 1Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia
- 2School of Allied Health (Exercise Science), Murdoch University, Perth, Western Australia, Australia
- 3The Kids Research Institute, Perth Children's Hospital, Perth, Western Australia, Australia
- 4Mucosal Immunology and Biology Research Center, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, United States of America
- 5Department of Paediatrics, Harvard Medical School, Boston, Massachusetts, United States of America
- 6School of Diagnostic and Therapeutic Sciences, Curtin University, Perth, Western Australia, Australia
- 7Curtin Medical Research Institute, Curtin University, Perth, Western Australia, Australia
- 8Dementia Centre of Excellence, enAble Institute, Curtin University, Perth, Western Australia, Australia
- 9Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, London, United Kingdom
- 10School of Medicine, The Hong Kong University of Science and Technology, Hong Kong, China
- 11Section of Nutrition, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom
- 12Burn Injury Research Unit, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia
- 13Fiona Wood Foundation, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
- 14WA Department of Health, Burns Service of Western Australia, Perth, Western Australia, Australia
- 15School of Medical, Molecular and Forensic Sciences, Murdoch University, Perth, Western Australia, Australia
- 16School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia
Abstract
Paediatric burn traumas are a global health concern shown to have long-term health consequences leading to increased morbidity and mortality. However, the underlying mechanisms contributing to these long-term health risks remain poorly understood. This study utilised 1H Nuclear Magnetic Resonance spectroscopy to comprehensively determine the lipoproteomic changes in the acute injury phase and long-term perturbations in blood samples longitudinally collected from 142 patients. In the acute phase of burn injury 55% of the lipoprotein main fractions and subfractions were significantly altered compared to non-burn controls. The plasma profiles from the burn injury group demonstrated increased LDL (low density lipoprotein) triglyceride concentrations (adjusted p-value = 2.12x10-9), an increased Apolipoprotein B100/Apolipoprotein A1 ratio (adjusted p-value = 4.29x10-5) and decreased HDL (High Density Lipoprotein, adjusted p-value = 1.16x10-11). At 1-year post-burn injury, it was found that 53% of the lipoprotein fraction and subfractions were altered compared to non-burn controls. The lipoproteomic profile showed a shift in LDL subfraction distribution, with a decrease in larger LDL subfractions (LDL subfraction 2 particle number, adjusted p-value = 2.52 × 10−4) and an increase in smaller LDL subfractions (LDL subfraction 6 particle number, adjusted p-value = 6.47 × 10−5), a pattern previously associated with cardiometabolic and cardiovascular risk. Significant lipid compositional changes of VLDL (very-low density lipoprotein), IDL (intermediate density lipoprotein), LDL and HDL were also observed at 1-year post-burn injury, notably the largest shifts were observed in IDL compared with non-burn controls. The proportion of cholesterol esters were markedly increased from 31.3% to 40.6%, free cholesterol increased from 12.8% to 15.1%, while phospholipids reduced from 29.5% to 23.3% and triglycerides reduced from 26.3% to 21.1%. Overall, this study demonstrates persistent lipoproteomic alterations following paediatric burn injury. These findings identify persistent metabolic perturbations that are not captured by conventional lipid measures, but further longitudinal studies incorporating inflammatory biomarkers and clinical cardiovascular outcomes are required to determine their clinical significance and relationship to future cardiovascular health.
Related
- Direct Remnant Lipoprotein Profiling Reveals Subfraction-Level Associations with Biopsy-Proven MASH in Severe Obesity
- Hypoxia drives asymmetric envelope remodelling to promote membrane adaptation and antibiotic tolerance in mycobacteria
- Direct measurement of PET hydrolase interfacial kinetics reveals catalysis-independent surface remodelling
- Senescent Cell‐Derived Extracellular Vesicles in Therapy‐Induced Senescence: Immune Remodelling and Emerging Links to Mitochondrial Stress in Cancer
- Larval diet drives remodelling of the peritrophic matrix in the Australian sheep blowfly and influences vaccine efficacy
BibTeX
@article{ryan2026blood,
title = {{Blood lipoprotein remodelling after non-severe paediatric burns: A longitudinal analysis beyond the acute phase}},
author = {Monique J. Ryan and Chloe Scott and Nathan G. Lawler and Reika Masuda and Jacqueline A. Davis and Nina D’Vaz and Lael M. Yonker and Maureen M. Leonard and Alessio Fasano and Luke Whiley and Jeremy K. Nicholson and Elaine Holmes and Fiona M. Wood and Samantha Lodge},
journal = {PLOS One},
year = {2026},
month = nov,
doi = {10.1371/journal.pone.0362177},
url = {https://doi.org/10.1371/journal.pone.0362177},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Blood lipoprotein remodelling after non-severe paediatric burns: A longitudinal analysis beyond the acute phase
AU - Monique J. Ryan
AU - Chloe Scott
AU - Nathan G. Lawler
AU - Reika Masuda
AU - Jacqueline A. Davis
AU - Nina D’Vaz
AU - Lael M. Yonker
AU - Maureen M. Leonard
AU - Alessio Fasano
AU - Luke Whiley
AU - Jeremy K. Nicholson
AU - Elaine Holmes
AU - Fiona M. Wood
AU - Samantha Lodge
PY - 2026
DA - 2026/11/12
JO - PLOS One
DO - 10.1371/journal.pone.0362177
UR - https://doi.org/10.1371/journal.pone.0362177
AB - Paediatric burn traumas are a global health concern shown to have long-term health consequences leading to increased morbidity and mortality. However, the underlying mechanisms contributing to these long-term health risks remain poorly understood. This study utilised 1H Nuclear Magnetic Resonance spectroscopy to comprehensively determine the lipoproteomic changes in the acute injury phase and long-term perturbations in blood samples longitudinally collected from 142 patients. In the acute phase of burn injury 55% of the lipoprotein main fractions and subfractions were significantly altered compared to non-burn controls. The plasma profiles from the burn injury group demonstrated increased LDL (low density lipoprotein) triglyceride concentrations (adjusted p-value = 2.12x10-9), an increased Apolipoprotein B100/Apolipoprotein A1 ratio (adjusted p-value = 4.29x10-5) and decreased HDL (High Density Lipoprotein, adjusted p-value = 1.16x10-11). At 1-year post-burn injury, it was found that 53% of the lipoprotein fraction and subfractions were altered compared to non-burn controls. The lipoproteomic profile showed a shift in LDL subfraction distribution, with a decrease in larger LDL subfractions (LDL subfraction 2 particle number, adjusted p-value = 2.52 × 10−4) and an increase in smaller LDL subfractions (LDL subfraction 6 particle number, adjusted p-value = 6.47 × 10−5), a pattern previously associated with cardiometabolic and cardiovascular risk. Significant lipid compositional changes of VLDL (very-low density lipoprotein), IDL (intermediate density lipoprotein), LDL and HDL were also observed at 1-year post-burn injury, notably the largest shifts were observed in IDL compared with non-burn controls. The proportion of cholesterol esters were markedly increased from 31.3% to 40.6%, free cholesterol increased from 12.8% to 15.1%, while phospholipids reduced from 29.5% to 23.3% and triglycerides reduced from 26.3% to 21.1%. Overall, this study demonstrates persistent lipoproteomic alterations following paediatric burn injury. These findings identify persistent metabolic perturbations that are not captured by conventional lipid measures, but further longitudinal studies incorporating inflammatory biomarkers and clinical cardiovascular outcomes are required to determine their clinical significance and relationship to future cardiovascular health.
SN - 1932-6203
ER -